Back to Browse Journals » Infection and Drug Resistance » Volume 5

Clinical update on linezolid in the treatment of Gram-positive bacterial infections

Authors Ager S, Gould K

Received 13 April 2012

Accepted for publication 20 April 2012

Published 25 June 2012 Volume 2012:5 Pages 87—102


Review by Single-blind

Peer reviewer comments 2

Sally Ager, Kate Gould

Department of Microbiology, Newcastle upon Tyne Hospitals Trust, Freeman Hospital, High Heaton, Newcastle upon Tyne, UK

Abstract: Gram-positive pathogens are a significant cause of morbidity and mortality in both community and health care settings. Glycopeptides have traditionally been the antibiotics of choice for multiresistant Gram-positive pathogens but there are problems with their use, including the emergence of glycopeptide-resistant strains, tissue penetration, and achieving and monitoring adequate serum levels. Newer antibiotics such as linezolid, a synthetic oxazolidinone, are available for the treatment of resistant Gram-positive bacteria. Linezolid is active against a wide range of Gram-positive bacteria and has been generally available for the treatment of Gram-positive infections since 2000. There are potential problems with linezolid use, including its bacteriostatic action and the relatively high incidence of reported adverse effects, particularly with long-term use. Long-term use may also be complicated by the development of resistance. However, linezolid has been shown to be clinically useful in the treatment of several serious infections where traditionally bacteriocidal agents have been required and many of its adverse effects are reversible on cessation. It has also been shown to be a cost-effective treatment option in several studies, with its high oral bioavailability allowing an early change from intravenous to oral formulations with consequent earlier patient discharge and lower inpatient costs.

Keywords: linezolid, oxazolidinone, multi-resistant, gram-positive, MRSA, VRE, cost-benefit

Download Article [PDF] View Full Text [HTML] 

Creative Commons License This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution - Non Commercial (unported, v3.0) License. The full terms of the License are available at Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at:

Readers of this article also read:

Impact of admission blood glucose level on outcomes in community-acquired pneumonia in older adults

Bhattacharya RK, Mahnken JD, Rigler SK

International Journal of General Medicine 2013, 6:341-344

Published Date: 6 May 2013


Bethany Spielman

Medicolegal and Bioethics 2011, 1:1-2

Published Date: 9 March 2011

The value of blood D-dimer test in the diagnosis of walk-in patients with venous thromboembolism

Shozo Yasuoka, Shunichiro Kubota

Vascular Health and Risk Management 2011, 7:125-127

Published Date: 1 March 2011

Colonic polyps: inheritance, susceptibility, risk evaluation, and diagnostic management

Emanuele Neri, Lorenzo Faggioni, Lorenzo Cini, et al

Cancer Management and Research 2011, 3:17-24

Published Date: 30 December 2010

Complexing proteins in botulinum toxin type A drugs: a help or a hindrance?

Jürgen Frevert, Dirk Dressler

Biologics: Targets and Therapy 2010, 4:325-332

Published Date: 9 December 2010

Improving management of patients with advanced cancer

Lawrence Drudge-Coates

Patient Preference and Adherence 2010, 4:415-424

Published Date: 2 December 2010

On the antiatherogenic effects of vitamin E: the search for the Holy Grail

Francesco Galli, Dimitrios Kirmizis, Dimitrios Chatzidimitriou

Vascular Health and Risk Management 2010, 6:69-71

Published Date: 16 February 2010

Discrimination between biological interfaces and crystal-packing contacts

Yuko Tsuchiya, Haruki Nakamura, Kengo Kinoshita

Advances and Applications in Bioinformatics and Chemistry 2008, 1:99-113

Published Date: 2 November 2008